Show simple item record

dc.contributor.authorTaboada, RG
dc.contributor.authorRiechelmann, R
dc.contributor.authorMauro, C
dc.contributor.authorBarros, M
dc.contributor.authorHubner, Richard A
dc.contributor.authorMcNamara, Mairead G
dc.contributor.authorLamarca, Angela
dc.contributor.authorValle, Juan W
dc.date.accessioned2020-06-15T12:57:43Z
dc.date.available2020-06-15T12:57:43Z
dc.date.issued2020en
dc.identifier.citationTaboada R, Riechelmann R, Mauro C, Barros M, Hubner RA, McNamara MG, et al. Everolimus-induced pneumonitis in patients with neuroendocrine neoplasms: multinational study on risk factors and outcomes. Neuroendocrinology. 2020;110: 240-.en
dc.identifier.urihttp://hdl.handle.net/10541/622998
dc.language.isoenen
dc.titleEverolimus-induced pneumonitis in patients with neuroendocrine neoplasms: multinational study on risk factors and outcomesen
dc.typeMeetings and Proceedingsen
dc.contributor.departmentA.C.Camargo Cancer Center, São Paulo, Brazilen
dc.identifier.journalNeuroendocrinologyen
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record